» Articles » PMID: 15828064

Differential Trk Expression in Explant and Dissociated Trigeminal Ganglion Cell Cultures

Overview
Journal J Neurobiol
Specialties Biology
Neurology
Date 2005 Apr 14
PMID 15828064
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

During embryonic development, expression of neurotrophin receptor tyrosine kinases (Trks) by sensory ganglia is continuously and dynamically regulated. Neurotrophin signaling promotes selective survival and axonal differentiation of sensory neurons. In embryonic day (E) 15 rat trigeminal ganglion (TG), NGF receptor TrkA is expressed by small diameter neurons, NT-3 receptor TrkC and BDNF receptor TrkB are expressed by large diameter neurons. Organotypic explant and dissociated cell cultures of the TG (and dorsal root ganglia) are commonly used to assay neurotrophin effects on developing sensory neurons. In this study, we compared Trk expression in E15 rat TG explant and dissociated cell cultures with or without neurotrophin treatment. Only a subset of TG cells express each of the three Trk receptors in wholemount explant cultures as in vivo conditions. In contrast, all TG neurons co-express all three Trk receptors upon dissociation, regardless of neurotrophin treatment. Neurons cultured in low concentrations of one neurotrophin first, and switched to higher concentrations of another after 1 day, survive and display morphological characteristics of neurons cultured in a mixture of both neurotrophins for 3 days. Our results indicate that wholemount explant cultures of sensory ganglia represent in vivo conditions in terms of Trk expression patterns; whereas dissociation dramatically alters Trk expression by primary sensory neurons.

Citing Articles

Oxygen matters: Unraveling the role of oxygen in the neuronal response to cisplatin.

Crugeiras J, Calls A, Contreras E, Alemany M, Navarro X, Yuste V J Peripher Nerv Syst. 2024; 29(4):528-536.

PMID: 39329299 PMC: 11625991. DOI: 10.1111/jns.12659.


Loss of Elp1 disrupts trigeminal ganglion neurodevelopment in a model of familial dysautonomia.

Leonard C, Quiros J, Lefcort F, Taneyhill L Elife. 2022; 11.

PMID: 35713404 PMC: 9273214. DOI: 10.7554/eLife.71455.


Ablation of sensory nerves favours melanoma progression.

Prazeres P, Leonel C, Silva W, Rocha B, Santos G, Costa A J Cell Mol Med. 2020; 24(17):9574-9589.

PMID: 32691511 PMC: 7520271. DOI: 10.1111/jcmm.15381.


Transcriptional Programming of Human Mechanosensory Neuron Subtypes from Pluripotent Stem Cells.

Nickolls A, Lee M, Espinoza D, Szczot M, Lam R, Wang Q Cell Rep. 2020; 30(3):932-946.e7.

PMID: 31968264 PMC: 7059559. DOI: 10.1016/j.celrep.2019.12.062.


Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: Prospects and limitations.

Lehmann H, Staff N, Hoke A Exp Neurol. 2019; 326:113140.

PMID: 31812556 PMC: 8926153. DOI: 10.1016/j.expneurol.2019.113140.


References
1.
Crowley C, Spencer S, Nishimura M, Chen K, Armanini M, Ling L . Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell. 1994; 76(6):1001-11. DOI: 10.1016/0092-8674(94)90378-6. View

2.
Karchewski L, Kim F, Johnston J, McKnight R, Verge V . Anatomical evidence supporting the potential for modulation by multiple neurotrophins in the majority of adult lumbar sensory neurons. J Comp Neurol. 1999; 413(2):327-41. DOI: 10.1002/(sici)1096-9861(19991018)413:2<327::aid-cne11>3.0.co;2-3. View

3.
Ernfors P, Lee K, Jaenisch R . Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature. 1994; 368(6467):147-50. DOI: 10.1038/368147a0. View

4.
Elkabes S, Dreyfus C, Schaar D, Black I . Embryonic sensory development: local expression of neurotrophin-3 and target expression of nerve growth factor. J Comp Neurol. 1994; 341(2):204-13. DOI: 10.1002/cne.903410206. View

5.
Yamashita T, Tucker K, Barde Y . Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron. 1999; 24(3):585-93. DOI: 10.1016/s0896-6273(00)81114-9. View